Can a Single-Use Laser Fiber Be Reused?

On 22 September 2026, a distributor or hospital buyer can be asked three different questions as if they were one question: whether this labeled single-use 1470 nm fiber may be autoclaved and used again; whether a reusable holmium-fiber instruction sheet can be attached to that carton; and whether a 510(k) title under product code GEX that never says "disposable" is a reuse clearance.¹⁷ The English search results for "single-use laser fiber reprocessing" do not separate those questions. Position 1 is a 2021 vendor cost article. Other results are holmium-fiber catalogues and opposing single-use and reusable IFU files.

The decision on the shipment is narrower than a universal ban and narrower than a clinic protocol. Accept the carton as the labeled single-use device. Send back a resterilization request, a borrowed reusable IFU, and a silent 510(k) title offered as permission. If someone else proposes to reprocess in the United States, the next document is that party's 510(k) under section 510(o) and the section 502(v) label, which this page does not supply. If the destination is the EU or EEA, the next document is the current Commission national-rules status and the identity of the reprocessor. If the destination is China, the registration's single-use statement stands, and a clinical-evaluation exemption code is not the statutory single-use catalogue.

Contents: 1. If the IFU says single-use, what exactly is the buyer refusing? · 2. Why is a reusable-fiber instruction sheet a different device? · 3. What does FDA require before reprocessing a Class II single-use device? · 4. Where does EU law allow single-use reprocessing? · 5. What does China Order 739 Article 49 decide? · 6. Why a silent GEX title cannot close the question · 7. What the search-result baseline gets wrong · 8. Accept or send back · Where VEMERIX fits · FAQ

If the IFU says single-use, what exactly is the buyer refusing: another clinical use, a resterilization cycle, or both?

When the carton and IFU say the fiber is supplied sterile for single use, the buyer is refusing both another clinical use and a resterilization cycle run by the clinic on that unit. ISO 15223-1:2021 reference 5.4.2 is the symbol for a device intended for one use, or for use on a single patient during a single procedure. Reference 5.2.6, used with a sterile symbol, means the device is not to be resterilized. Reference 5.2.8 means do not use the device if the package is damaged. It is not the resterilization symbol.¹⁴

A common operational version of the request is narrower than a second patient and still outside the label: the fiber was opened and not inserted, or the staff propose to clean it and return it to stock. A single-use statement does not contain a processing validation for that step. The buyer cannot treat optical transmission, tip integrity, or sterility after an extra cycle as established when the manufacturer did not document that cycle for this device. This page does not describe a cleaning agent, a temperature, a pressure, or a cycle count, because those parameters would be a protocol this label does not provide.

Two legal overreads should be sent back with the request. Resterilizing the unit does not, by itself, vacate the manufacturer's registration or 510(k) for units that are still used as labeled. VEMERIX's fiber record is an NMPA Class II registration, not an FDA clearance that a clinic could "void."⁸ And this page is not an opinion on product liability. What the US rule does say is a role statement: a hospital or third party that reprocesses a single-use device is regulated as the original manufacturer would be.¹ That is different from a claim that every court will shield the original manufacturer.

For the distributor, the commercial answer is the same in each of those cases. Do not grant permission to reprocess the labeled single-use SKU, do not supply an autoclave recipe, and do not accept a tender clause that requires this carton to withstand a stated number of cycles.

Why is a reusable-fiber instruction sheet a different device, not a missing page from the single-use carton?

Buyers often arrive with a reusable holmium-fiber IFU and ask why those cleaning and autoclave steps cannot be used on a single-use endovenous fiber. The sheet feels like a missing page because both objects are called laser fibers. On the documents, they are different devices. The reusable IFU names its own catalogue number, its own processing information, and any maximum number of uses the manufacturer validated for that SKU. None of those sentences transfers to a carton that says single use.

The vendor page at position 1 makes the opposite commercial claim. MedWorks writes that, while material quality varies, disposable and reusable fibers "are essentially identical in structure" and that the main difference is a chip that counts connections to the laser.⁹ That is a description of the surgical fibers MedWorks is discussing. It is not a validation report for a 1470 nm endovenous fiber, and it is not a reason to paste one manufacturer's steam table onto another manufacturer's single-use label. This guide does not extract temperatures, pressures, or cycle counts from any reusable IFU. Publishing those numbers would turn a boundary article into a protocol the single-use label does not contain.

• Keep the sheet on the device it names. If the IFU is for a reusable fiber, its processing information and any stated maximum number of uses stay with that catalogue number.
• Do not fill a gap in the single-use file. A single-use label that gives no reprocessing method is not completed by a competitor's reusable IFU.
• Do not treat a use-count chip as the regulatory difference. A chip, where a manufacturer uses one, is a feature of that labeled device. It is not FDA section 510(o), and it is not MDR Article 17.
• Send the protocol back. A distributor that forwards steam, gas, or cleaning parameters for a single-use SKU is no longer only identifying the product. This page stops at the document boundary.

What does FDA actually require before a hospital or a third party may reprocess a Class II single-use device?

FDA's health-care-facility page does not say that every single-use device is barred from reprocessing, and it does not say that a hospital may autoclave a single-use device on its own judgment. The page says both of the following.¹

The FDA ensures the safety and effectiveness of reprocessed SUDs by regulating device manufacturers, third party reprocessors, and hospitals that reprocess SUDs in the same manner as the original equipment manufacturer (OEM). In doing so, reprocessors of SUDs are held to the same regulatory requirements as the original manufacturer of the single use device.— FDA, Reprocessing Single-Use Medical Devices: Information for Health Care Facilities

The statutory definition is also easy to shorten in a way that changes it. The page, citing FD&C Act section 201(ll)(1), says single-use devices are "those devices intended for one use, or on a single patient during a single procedure." The "or" is part of the sentence.¹

For a Class I or Class II single-use device, section 510(o) requires a premarket notification with validation data for a specified maximum number of times the device is reprocessed, unless the device is expressly exempted from section 510(o). The page lists four items: cleaning; disinfection; sterilization, if required; and functional performance, including the rationale for that maximum number of cycles. The page does not state a sterility-assurance level, an endotoxin limit, or a bioburden method in that list. Those details, if they are required for a particular submission, belong in the reprocessor's 510(k), not in a paraphrase of this page.¹

Section 502(v), as printed on the same page, requires this label: "Reprocessed device for single use. Reprocessed by [the person or establishment responsible for reprocessing]." A reprocessed single-use device that lacks that statement is misbranded. The page also says that third-party reprocessors and health care facilities that reprocess single-use devices generally must meet the same postmarket requirements as the original manufacturer, and it names medical device reporting under 21 CFR Part 803, corrections and removals under 21 CFR Part 806, labeling under 21 CFR Part 801, and quality systems under 21 CFR Part 820.¹ This article follows that page. It does not add a quality-system label the page does not use.

However, the absence of reprocessing validation testing by the OEM does not mean the device is unable to be reprocessed.— FDA, Reprocessing Single-Use Medical Devices: Information for Health Care Facilities

That sentence is the correction to a search summary that says single-use fibers must never be reprocessed. FDA says an original manufacturer may have labeled the device for single use because it did not test reuse, or because it chose not to market reuse. The sentence is not a permission for the distributor, or for the clinic that bought the carton, to run a cycle. The burden of demonstrating that a reprocessed device remains substantially equivalent sits on the reprocessor's submission. Class III reprocessed devices are a different route on the same page, a premarket report under section 515(c), and they are outside a GEX Class II fiber question.¹

Where does EU law allow single-use reprocessing, and why is a country on the Commission table not a fiber-level permission?

Article 17 of Regulation (EU) 2017/745 starts with a national-law gate, not a device list:⁴

Reprocessing and further use of single-use devices may only take place where permitted by national law and only in accordance with this Article.— Regulation (EU) 2017/745, Article 17

Where a country does permit reprocessing, the article does not have only one pathway. Under Article 17(2), a person who reprocesses a single-use device to make it suitable for further use in the Union is considered the manufacturer of the reprocessed device and assumes the manufacturer obligations in the Regulation, including traceability under Chapter III. That person is also considered a producer for Article 3(1) of Directive 85/374/EEC. Article 17(3) is a derogation: for devices reprocessed and used inside a health institution, a Member State may decide not to apply all manufacturer rules, but only if the reprocessed device's safety and performance are equivalent to the original device and reprocessing follows common specifications. Those specifications cover risk management, validation of the whole process including cleaning, release and performance testing, the quality management system, incident reporting, and traceability. Article 17(5) says compliance with the common specifications is certified by a notified body. Commission Implementing Regulation (EU) 2020/1207 is the instrument that lays down those common specifications. It is not a fiber cycle.⁴¹⁰ Article 17(4) lets a Member State extend the health-institution route to an external reprocessor, if the whole device is returned to that institution and the external reprocessor meets the Article 17(3) requirements.

The Commission keeps the national notifications public.² The page checked for this article says it reflects notifications up to January 2025. Table 1 names Belgium, Croatia, Germany, Iceland, Ireland, Poland, Portugal, the Netherlands, Spain, and Sweden. The page calls the Table 1 countries EU countries, while Iceland is an EEA country on that table. A separate bullet list names 18 countries that do not authorise reprocessing, including France and Italy, and also including the EEA countries Liechtenstein and Norway. The colours that would show each Table 1 country's Article 17(2), 17(3), 17(4), or 17(9) choice did not survive as text, so this page does not assign those tick marks.

COM(2024) 560 final, dated 29 November 2024, is an earlier snapshot. It reports data from December 2022 to December 2023 across 30 countries and says 10 had adopted rules allowing reprocessing — the same ten names — and 20 had not.³ Those 20 include Luxembourg and Slovenia, which are not in the January 2025 do-not-authorise bullets. The two sources are not added together, and neither source is a list of laser fibers.

Making available or further reuse of reprocessed single-use devices in Poland is prohibited.— European Commission, national rules on reprocessing of single-use devices, footnote to Table 1, notifications through January 2025

Poland is on Table 1 and still carries that footnote. Article 17(9) allows a Member State that permits reprocessing to keep stricter national rules that restrict or prohibit, on its territory, the making available or further use of reprocessed single-use devices.⁴ The footnote is the public statement a buyer can apply. It is not, by itself, a reading of which coloured cell Poland ticked. A customer who points at Germany, Belgium, or any other Table 1 name has shown a jurisdictional entry, not a CE certificate for a reprocessed endovenous fiber, and not evidence that this fiber is on a hospital reprocessing list.

What does China Order 739 Article 49 decide, and what does the missing catalogue row leave open?

State Council Order No. 739 has been in force since 1 June 2021. Article 49 is broader than a sentence that applies only to devices already printed in a catalogue. The Chinese text distinguishes reusable devices, which the user processes under health-authority disinfection rules, from single-use devices. An English rendering of the single-use sentences on the State Council gazette is:⁵

A single-use medical device shall not be reused. A used single-use medical device shall be destroyed and recorded in accordance with the relevant national provisions. The catalogue of single-use medical devices shall be formulated, adjusted, and published by the drug regulatory department of the State Council jointly with the health authority of the State Council. Listing in that catalogue requires sufficient evidence that the device cannot be reused. A medical device that can assure safety and effectiveness when reused is not listed. A device that, after a change in design, manufacturing process, or disinfection and sterilization technology, can assure safety and effectiveness when reused shall be removed from the catalogue, and reuse is then permitted.— English rendering of State Council Order No. 739, Article 49, State Council gazette. Not an official English translation.

NHC Order No. 8 has been in force since 1 March 2021. Article 28 tells the medical institution, not the catalogue editor, that a single-use medical device shall not be reused and that a used one shall be destroyed and recorded under the relevant national provisions. Devices that regulations allow to be reused are cleaned, disinfected, or sterilized as required, and the effect is monitored.⁶ The article does not say destruction must be immediate, and it does not name laser fibers.

Article 90(2) of Order 739 is the penalty hook for a user that reuses a single-use medical device, or that does not destroy a used single-use medical device as required. The health authority orders correction and gives a warning. If the user does not correct the violation, the fine is RMB 50,000 to 100,000. In a serious case the fine is RMB 100,000 to 300,000, with suspension of the relevant device-use activity, up to revocation of the practice license by the original licensing authority. The penalty text is not limited to the words "devices already printed in the catalogue."⁵

The catalogue question is still real. Article 49 says the drug regulator and the health authority publish the list, and that devices which can be reused safely are not put on it. A search of public NMPA and NHC catalogue pages on 22 September 2026 did not locate a row naming a medical laser fiber. That negative result is a limit of the search. It is not a finding that the fiber sits outside Article 49, and it is not permission for a hospital to resterilize a device whose registration and label say single use.

A second catalogue is easy to mix in. NMPA Announcement 2025 No. 19, dated 12 May 2025, is the catalogue of medical devices exempt from clinical evaluation. Public copies of the attachment place code 01-02-02, medical laser optical fiber, in that list. The product description in those copies is a fiber used to transmit laser light for laser surgery whose output end is a straight flat cut.¹³ That row decides a registration clinical-evaluation question for the device described there. It is not Order 739's single-use catalogue, and a straight flat-cut description is not a radial endovenous fiber. Offering code 01-02-02 as proof that a 1470 nm endovenous fiber may be reused is a document error. Send it back.

For a fiber registered as single use, including the VEMERIX disposable medical laser fiber under Lu Mech Reg. 20192010517, the approved registration and the label are the product being supplied.⁸ A clinic note does not amend that registration. This page does not describe an NMPA change form and does not claim that a provincial interpretation was re-opened for this article. The practical send-back is enough: do not resterilize the labeled single-use fiber, and do not treat a missing catalogue row, or a clinical-evaluation exemption code, as a reusable IFU.

Why a GEX 510(k) title that never says reusable or single-use cannot close the question

Product code GEX is FDA's product code for a powered laser surgical instrument, regulation number 878.4810, Class 2, with a 510(k) submission type.⁷ The classification regulation's identification text names a carbon dioxide laser for general surgery and dermatology, and an argon laser for dermatology. It does not mention an optical fiber, and it does not state a single-use or reusable rule.¹² Fiber clearances in the count below are records FDA coded as GEX. They are not a finding that the regulation's identification paragraph is a fiber definition.

A tender sometimes treats the public device name as the reuse rule: if the title says "surgical laser fiber" and does not say "disposable," FDA has cleared reuse. To test that reading, this page recomputed a name-token count from the FDA 510(k) public-export snapshot dated 22 July 2026, which contains 175,559 rows. The filter was product code GEX and a device name matching fiber or fibre, without regard to case. That filter returned 226 rows. The decision field on all 226 was substantially equivalent. Decision dates inside the filter ran from 7 February 1986 through 18 June 2026. The export does not include clearances after 22 July 2026.

Seven of the 226 titles are thulium fiber-laser systems or system families, not fiber-only clearances: K232568, K252971, K211517, K252787, K251303, K242987, and K242293. K232568 names an IPG Medical family of thulium fiber lasers, surgical fibers, and accessories, so the exclusion is a sensitivity choice: it is a system-family clearance, not a fiber-only 510(k). None of the seven titles contained a reusable or single-use or disposable token. After that exclusion, 219 names remained. A name was counted as reusable if it contained "reusable," and as single-use or disposable if it contained "single-use," "single use," or "disposable."

The result is a statement about titles, not about the US laser-fiber market. It is not true that 87.2% of cleared medical laser fibers in the United States are silent. The denominator is 219 GEX names in one export after a stated exclusion. Names are not IFUs. Zero of the 226 names matched the tokens endovenous, varicose, EVLT, or EVLA. That four-token result is not the same as "no venous fiber is in the file." K130681, which remains inside the silent group, is titled ENDOVASCULAR LASER VENOUS SYSTEM KIT WITH 2 RING RADIAL EMITTING FIBER. A buyer who needs the register split between a fiber, a generator, and a kit should use how public registers separate endovenous fibers, generators, and kits rather than this name count.

K252745 shows what a title looks like when it does say single-use. K140366 shows what a title looks like when it says reusable. K201171 shows why one K number can be a poor yes-or-no answer: the public name lists a disposable bare fiber, a reusable bare fiber, and a disposable endoprobe. When the title is silent, the 510(k) summary and the commercial IFU are the documents that still have to be opened. For the market-entry file around a single-use endovenous fiber, see registering a single-use endovenous laser fiber. This count is not that file, and it is not a new adverse-event tally. Readers who want the surveillance limits should use FDA MAUDE and recall signals for endovenous laser fibers, which does not convert report counts into breakage incidence.

Correcting the SERP baseline: MedWorks claims and the Google AI Overview

The query checked on 22 September 2026 mixed a vendor article, manufacturer catalogues, and IFU files. An AI Overview on that query told readers that single-use surgical laser fibers must never be reprocessed, then described reusable fibers in the language of those vendor pages. MedWorks, the organic position 1 result, is a sales article dated 20 April 2021.⁹ The FDA page is the primary text those summaries leave out.¹

The 2014 abstract also excludes the purchase cost of the ureterorenoscopes and the laser equipment, and it excludes staffing and hospital stay.¹¹ MedWorks' own page, after the per-case illustration, says reprocessing and scope damage can leave reusable fibers short of the apparent saving, and it quotes the abstract's disposable-fiber conclusion.⁹ The correction is not that reusable fibers are always more expensive. The correction is that this ureteroscopy repair study, and those illustrative dollars, do not price a single-use 1470 nm endovenous fiber.

Distributor checklist: accept the labeled single-use fiber, or send back a resterilization request

Use the five gates below on the file in front of you. A passing gate identifies the labeled single-use device. A failing gate is a send-back. None of the gates asks the distributor to supply a sterilization cycle.

Where VEMERIX fits—and where due diligence still begins

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care. In this vascular line, Medison manufactures the NMPA-registered disposable medical laser fiber, Class II, Lu Mech Reg. 20192010517.⁸

The public product record describes that fiber as single-use, sterile, and individually packed, designed for 1470 nm endovenous laser workflows, with multiple tip geometries for vein work, and paired with a partner-supplied diode laser source. The same record does not state an FDA 510(k), a CE certificate, or a reusable-fiber validation for this fiber. This page does not add clinical performance claims, including energy-distribution or perforation claims, that the product record does not state.

The partner-supplied NOVACURE Semiconductor Laser Treatment System is a separate capital device, NMPA Class III, Guo Xie Zhu Zhun 20253011190, with Guangdong Yunshang as the registration holder. It is not a Medison-manufactured console, and it is not reprocessed under the fiber's single-use file. The fiber's single-use label does not make the console single-use. The console's status as capital equipment does not make the fiber reusable. This page does not provide a console cleaning method.

Due diligence starts with the label on the shipment: the single-use statement, the registration number, and the destination rule in the checklist above. Specification questions that are not reuse questions — wavelength, connector, core, tip geometry, and introducer match — belong in the 1470 nm radial fiber specifications and compatibility guide. Which laser-safety file belongs with the shipment is a separate incoming check: which laser-safety file belongs with a 1470 nm fiber shipment. Product, quality, and document requests go through the Disposable Medical Laser Fiber page, the quality page, downloads, and contact.

Frequently Asked Questions

Does a single-use label mean FDA has banned every future reprocessing submission?
No. FDA states that the absence of reprocessing validation testing by the OEM does not mean the device is unable to be reprocessed.¹ A Class I or Class II reprocessor still submits a 510(k) under section 510(o), unless expressly exempted, with cleaning, disinfection, sterilization if required, and functional-performance data for a stated maximum number of cycles, and applies the section 502(v) label. That route is not an in-house clinic cycle, and it is not a document the distributor can copy from a reusable IFU.

Can a distributor copy a reusable fiber's sterilization instruction onto a single-use 1470 nm fiber?
No. The reusable IFU is the processing information for the device it names. The single-use label does not incorporate it. This page does not print the reusable device's temperatures or cycle counts, because those figures would be a protocol for a different product.

Does a 510(k) number under product code GEX prove the fiber may be reused?
No. GEX is the powered laser surgical instrument code under 21 CFR 878.4810, and the regulation text does not state a reuse rule.⁷¹² In the 22 July 2026 export, 191 of 219 GEX fiber-or-fibre names were silent on reuse after seven thulium-system titles were removed. A silent title is not a determination. K252745 is an example of a title that does say single-use. K140366 is an example that says reusable.

If a Member State allows single-use reprocessing, may this fiber be reprocessed there without anyone taking on manufacturer obligations?
Not on the strength of the country name alone. Article 17(2) considers the reprocessor to be the manufacturer. Article 17(3) lets a Member State disapply some of those manufacturer rules for reprocessing inside one health institution, but only with equivalent safety and performance and the common specifications, and Article 17(5) requires a notified body to certify compliance with those specifications.⁴¹⁰ Poland remains a send-back under the Commission footnote even though Poland is on Table 1.²

Is a medical laser fiber on China's statutory single-use catalogue because the registration says single-use?
This page did not locate a catalogue row for a medical laser fiber on 22 September 2026. Order 739 Article 49 still says a single-use medical device shall not be reused, and NHC Order 8 Article 28 says the same to the medical institution.⁵⁶ The registration and label fix the device being supplied. A missing row is not a reusable status.

Is NMPA Announcement 2025 No. 19 the statutory single-use catalogue?
No. It is the catalogue of medical devices exempt from clinical evaluation. Public copies place code 01-02-02, medical laser optical fiber, in that list and describe a straight flat-cut output end.¹³ That is not Order 739 Article 49, and it is not a description of a radial endovenous fiber.

Does VEMERIX claim a reusable-fiber validation or an FDA 510(k) for this fiber?
No. The public product record is an NMPA Class II single-use fiber, Lu Mech Reg. 20192010517, for 1470 nm endovenous workflows, used with a partner-supplied diode source.⁸ It does not state an FDA 510(k), a CE certificate, or a reusable validation.

Does the partner-supplied laser console become single-use because the fiber is single-use?
No. NOVACURE is a separate partner-supplied NMPA Class III capital device, Guo Xie Zhu Zhun 20253011190, registration holder Guangdong Yunshang. It is not manufactured by Medison, and it is not reprocessed under the fiber label. The fiber does not become reusable because the console is capital equipment. This page does not give a console cleaning instruction.